CLINICAL_TRIALS
trial_result
· 2024-04-24
Clinical Trial Update: Safety, Efficacy and Pharmacokinetics of CBT-006 in Patients With Meibomian Gland Dysfunction [Phase 2]
Summary
Phase 2 clinical trial evaluating safety, efficacy, and pharmacokinetics of CBT-006 in patients with Meibomian Gland Dysfunction has completed with results post…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Cloudbreak Therapeutics, LLC | Conditions: Meibomian Gland Dysfunction | Phase 2 | Status: COMPLETED | Results posted: 2024-04-24